MedTech – Vitalizing Ayushman Bharat

For ensuring the takeoff of AB-PMJAY, the MedTech industry has a huge responsibility. Huge financial resources and investments at various levels, with government support is one of the major pre-requisites, and this leap is an essential condition for its success....

The many challenges ahead of Ayushman Bharat

Free healthcare doesn’t necessarily mean quality healthcare — and Indians are ruthless with their expectations of quality. Say you are the government. How do you know a mega scheme meant to lift millions from suffering isn’t panning out the way you wanted? When it...

MTaI to organize ‘MTaI MedTekon 2018’ on 20th September

Healthcare experts will discuss ways to contribute to Pradhan Mantri Jan Arogya Abhiyan (PRAJAA) while sustaining growth momentum New Delhi: Medical Technology Association of India (MTaI) is organizing  the ‘MTaI MedTekon 2018’ to bring together healthcare experts for...

Dr. VK Paul to inaugurate MTaI MedTekon 2018

NITI Aayog Member Dr. Vinod K. Paul will inaugurate MTaI MedTekon 2018 in New Delhi on September 20, as industry leaders come together to envision the role of the MedTech industry in the implementation of Ayushman Bharat, formally known as Pradhan Mantri Jan...

MTaI to organise MTaI MedTekon 2018 in September

Healthcare experts will discuss ways to contribute to PRAJAA while sustaining growth momentum Medical Technology Association of India (MTaI), which represents leading research-based medical technology companies with significant investments in India, is organising...

Global medical device makers unhappy over stent price cap

The Medical Technology Association of India (MTAI), a representative body of the domestic arms of global medical device makers, has expressed concern over the government move to cap the prices of cardiac stents. “The government must not undercut the market...

10% price hike cap on most medical devices

NEW DELHI: The prices of all medical devices except for stents, condoms and intrauterine devices can only be raised by up to 10% in a year, the National Pharmaceutical Pricing Authority (NPPA) said in a new office order on Friday. The drug price regulator also...